Successful treatment of PD-1 inhibitor-induced psoriasis with infliximab

J Eur Acad Dermatol Venereol. 2023 May;37(5):e621-e623. doi: 10.1111/jdv.18780. Epub 2022 Nov 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Dermatologic Agents* / adverse effects
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Infliximab / adverse effects
  • Psoriasis* / chemically induced
  • Psoriasis* / drug therapy
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha

Substances

  • Infliximab
  • Immune Checkpoint Inhibitors
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha